Growth Metrics

Fulgent Genetics (FLGT) Non-Current Assets (2016 - 2026)

Fulgent Genetics' Non-Current Assets history spans 12 years, with the latest figure at $677.3 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 14.15% to $677.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.8 billion, a 16.99% decrease, with the full-year FY2025 number at $663.0 million, down 23.47% from a year prior.
  • Non-Current Assets hit $677.3 million in Q1 2026 for Fulgent Genetics, up from $663.0 million in the prior quarter.
  • Over the last five years, Non-Current Assets for FLGT hit a ceiling of $907.2 million in Q3 2024 and a floor of -$534.6 million in Q4 2022.
  • Historically, Non-Current Assets has averaged $698.7 million across 5 years, with a median of $786.5 million in 2022.
  • Biggest five-year swings in Non-Current Assets: plummeted 180.18% in 2022 and later skyrocketed 236.07% in 2023.
  • Tracing FLGT's Non-Current Assets over 5 years: stood at -$534.6 million in 2022, then skyrocketed by 236.07% to $727.5 million in 2023, then increased by 19.09% to $866.4 million in 2024, then dropped by 23.47% to $663.0 million in 2025, then grew by 2.16% to $677.3 million in 2026.
  • Business Quant data shows Non-Current Assets for FLGT at $677.3 million in Q1 2026, $663.0 million in Q4 2025, and $707.2 million in Q3 2025.